The latest emerging drugs for the treatment of diabetic cardiomyopathy

M Li, L Liu, C Zhang, L Deng, Y Zhong… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Diabetic cardiomyopathy (DCM) is a serious complication of diabetes mellitus
involving multiple pathophysiologic mechanisms. In addition to hypoglycemic agents …

Progress in the treatment of diabetic cardiomyopathy, a systematic review

Y Shou, X Li, Q Fang, A Xie, Y Zhang… - Pharmacology …, 2024 - Wiley Online Library
Diabetic cardiomyopathy (DCM) is a condition characterized by myocardial dysfunction that
occurs in individuals with diabetes, in the absence of coronary artery disease, valve disease …

Pathogenesis and drug intervention of diabetic cardiomyopathy: a review

H TONG, C ZHANG, M HAN, G SUN… - Chinese Journal of …, 2022 - pesquisa.bvsalud.org
Diabetic cardiomyopathy, one of the cardiovascular complications of diabetes, is
characterized by cardiac systolic and diastolic dysfunction at the early stage, which can later …

Clinical approach to diabetic cardiomyopathy: a review of human studies

R Tarquini, L Pala, S Brancati, G Vannini… - Current Medicinal …, 2018 - ingentaconnect.com
Background: Diabetic Cardiomyopathy (DC) has been defined as a distinct entity
characterized by the presence of diastolic or systolic cardiac dysfunction in a diabetic patient …

Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy

B Parim, VV Sathibabu Uddandrao, G Saravanan - Heart Failure Reviews, 2019 - Springer
Diabetic complications are among the largely exigent health problems currently.
Cardiovascular complications, including diabetic cardiomyopathy (DCM), account for more …

[HTML][HTML] Novel insights into the pathogenesis of diabetic cardiomyopathy and pharmacological strategies

F Muñoz-Córdova, C Hernández-Fuentes… - Frontiers in …, 2021 - frontiersin.org
Diabetic cardiomyopathy (DCM) is a severe complication of diabetes developed mainly in
poorly controlled patients. In DCM, several clinical manifestations as well as cellular and …

[HTML][HTML] A Review on the Natural Products in Treatment of Diabetic Cardiomyopathy (DCM)

P Yao, X Yang, Y Qiao - Reviews in Cardiovascular Medicine, 2024 - imrpress.com
Diabetic cardiomyopathy is an insidious and fatal disease, imposing major financial and
social burdens on affected individuals. Among the various methods proposed for the …

Phytochemicals as prototypes for pharmaceutical leads towards drug development against diabetic cardiomyopathy

S Ojha, A Kurdi, B Sadek, M Kaleem… - Current …, 2016 - ingentaconnect.com
Globally diabetes mellitus (DM) is swiftly reaching epidemic proportions and impose major
health care and socio-economic challenges that are associated with its complications. DM is …

A comprehensive review of the novel therapeutic targets for the treatment of diabetic cardiomyopathy

A Dhar, J Venkadakrishnan, U Roy… - Therapeutic …, 2023 - journals.sagepub.com
Diabetic cardiomyopathy (DCM) is characterized by structural and functional abnormalities
in the myocardium affecting people with diabetes. Treatment of DCM focuses on glucose …

Cellular mechanisms and recommended drug-based therapeutic options in diabetic cardiomyopathy

L Dannenberg, S Weske, M Kelm, B Levkau… - Pharmacology & …, 2021 - Elsevier
Diabetes mellitus (DM) is associated with a specific cardiac phenotype characterized by
structural and functional alterations. This so-called diabetic cardiomyopathy (DM CM) is …